Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amalia N. Anastasopoulou
Observed names:
A. Anastasopoulou,
Amalia Anastasopoulou,
Amalia Anastatopoulou,
Amalia N Anastasopoulou,
Anastasopoulou, Amalia
Institutions:
National and Kapodistrian University of Athens,
Laiko General Hospital of Athens
Observed institutions:
The University of Texas MD Anderson Cancer Center,
National and Kapodistrian University of Athens,
General University Hospital of Patras,
Laiko General Hospital of Athens,
Ospedale Policlinico San Martino
ORCID:
0000-0002-2147-7583
Observed ORCID:
0000-0002-2147-7583
OpenAlex ID:
A5080248261
Therapy of Mucormycosis
2018
·
Nikolaos V. Sipsas
, Maria N. Gamaletsou
, et al.
·
Journal of Fungi
·
202
PDF
Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations
2019
·
Amalia Anastasopoulou
, Dimitrios C. Ziogas
, et al.
·
Journal for ImmunoTherapy of Cancer
·
124
PDF
Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma
2019
·
Eva Kassi
, Anna Angelousi
, et al.
·
Cancer Medicine
·
58
PDF
When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
2020
·
Dimitrios C Ziogas
, Aikaterini Gkoufa
, et al.
·
Journal for ImmunoTherapy of Cancer
·
43
PDF
Bullous Pemphigoid–like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature
2018
·
Amalia Anastasopoulou
, Georgios Papaxoinis
, et al.
·
Journal of Immunotherapy
·
42
Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy
2020
·
Dimitrios C Ziogas
, Frosso Kostantinou
, et al.
·
Journal for ImmunoTherapy of Cancer
·
39
PDF
Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection
2022
·
Vasiliki Georgakopoulou
, Sotiria Makrodimitri
, et al.
·
Molecular Medicine Reports
·
38
PDF
New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3
2024
·
Ioannis-Alexios Koumprentziotis
, Charalampos Theocharopoulos
, et al.
·
Vaccines
·
37
PDF
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
2024
·
Jon Salmanton-García
, Francesco Marchesi
, et al.
·
EClinicalMedicine
·
35
PDF
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
2023
·
Jon Salmanton-García
, Francesco Marchesi
, et al.
·
EClinicalMedicine
·
34
Inflammatory Myopathy and Axonal Neuropathy in a Patient With Melanoma Following Pembrolizumab Treatment
2017
·
Panagiotis T. Diamantopoulos
, Katerina Tsatsou
, et al.
·
Journal of Immunotherapy
·
34
Late-onset nivolumab-mediated pneumonitis in a patient with melanoma and multiple immune-related adverse events
2017
·
Panagiotis T. Diamantopoulos
, Maria Gaggadi
, et al.
·
Melanoma Research
·
30
Incomplete Vogt–Koyanagi–Harada disease following treatment with encorafenib and binimetinib for metastatic melanoma
2018
·
Panagiotis T. Diamantopoulos
, Sofia Stoungioti
, et al.
·
Melanoma Research
·
29
Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies
2023
·
Amalia Anastasopoulou
, Michael Samarkos
, et al.
·
Open Forum Infectious Diseases
·
22
PDF
State-of-the-art in Metastatic Uveal Melanoma Treatment: A 2025 Update
2025
·
Dimitrios C. Ziogas
, Dimitra Foteinou
, et al.
·
Current Oncology Reports
·
20
PDF
Non‐Aspergillus invasive mould infections in patients treated with ibrutinib
2020
·
Amalia Anastasopoulou
, Adam J. DiPippo
, et al.
·
Mycoses
·
20
The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature
2021
·
Amalia Anastasopoulou
, Panagiotis T. Diamantopoulos
, et al.
·
Therapeutic Advances in Medical Oncology
·
18
Clinical benefit of immune checkpoint inhibitors in elderly cancer patients: Current evidence from immunosenescence pathophysiology to clinical trial results
2025
·
Dimitrios C. Ziogas
, Charalampos Theocharopoulos
, et al.
·
Critical Reviews in Oncology/Hematology
·
17
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA ‐ EPIFLUEHA Report
2024
·
Jon Salmanton‐García
, Francesco Marchesi
, et al.
·
American Journal of Hematology
·
17
Correlation of Fc-γ RIIA polymorphisms with latent Epstein–Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas
2012
·
Panagiotis T. Diamantopoulos
, Vassiliki Kalotychou
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
17
Concomitant development of neurologic and cardiac immune-related adverse effects in patients treated with immune checkpoint inhibitors for melanoma
2020
·
Panagiotis T. Diamantopoulos
, Katerina Tsatsou
, et al.
·
Melanoma Research
·
13
Prognosis and Management of BRAF V600E-Mutated Pregnancy-Associated Melanoma
2020
·
Dimitrios C. Ziogas
, Panagiotis Diamantopoulos
, et al.
·
The Oncologist
·
12
PDF
Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers
2022
·
Dimitrios C. Ziogas
, Anastasios Martinos
, et al.
·
Cancers
·
11
PDF
Visceral Leishmaniasis in a Rheumatoid Arthritis Patient Treated With Methotrexate
2012
·
Grigorios S. Karagiannidis
, Marina Mantzourani
, et al.
·
JCR Journal of Clinical Rheumatology
·
11
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
2024
·
Tobias Lahmer
, Jon Salmanton-García
, et al.
·
Infection
·
10
Show more works
View as search
Works count:
82
Citation count:
1,033
H-index:
17
I10-index:
25
Year
Topic
Type
